274 related articles for article (PubMed ID: 10472326)
1. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
5. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
6. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activation in colorectal carcinogenesis.
Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
J Pathol; 1999 Oct; 189(2):207-12. PubMed ID: 10547576
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Lukman K; Maskoen AM; Achmad TH; Hanafi B; Karnadihardja W
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():491-7. PubMed ID: 10895200
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
11. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
Matsubara N; Hietala OA; Gilmour SK; Yum KY; Litwin S; Watts P; Brennan ; O'Brien
Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
Li JQ; Wu F; Masaki T; Kubo A; Fujita J; Dixon DA; Beauchamp RD; Ishida T; Kuriyama S; Imaida K
Int J Oncol; 2004 Jul; 25(1):87-95. PubMed ID: 15201993
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of telomerase in the development and progression of colon cancer.
Boldrini L; Faviana P; Gisfredi S; Zucconi Y; Di Quirico D; Donati V; Berti P; Spisni R; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Int J Mol Med; 2002 Nov; 10(5):589-92. PubMed ID: 12373297
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
Bautista CV; Felis CP; Espinet JM; García JB; Salas JV
Dis Colon Rectum; 2007 May; 50(5):611-20. PubMed ID: 17297554
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Tahara H; Kuniyasu H; Yokozaki H; Yasui W; Shay JW; Ide T; Tahara E
Clin Cancer Res; 1995 Nov; 1(11):1245-51. PubMed ID: 9815918
[TBL] [Abstract][Full Text] [Related]
17. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
18. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Chadeneau C; Hay K; Hirte HW; Gallinger S; Bacchetti S
Cancer Res; 1995 Jun; 55(12):2533-6. PubMed ID: 7780964
[TBL] [Abstract][Full Text] [Related]
20. Metastatic potential of colorectal adenoma containing carcinoma determined by pre-operative assessment of morphology.
Orita H; Matsusaka T; Korenaga D; Ikeda T; Sugimachi K
Hepatogastroenterology; 1997; 44(14):452-7. PubMed ID: 9164518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
